Up to date with medac

Since May, Dr Christian Matschke has strengthened the Management Board of the medac Group as Chief Operating Officer (COO). His responsibilities focus on stable manufacturing and supply structures, high quality standards, and the reliable supply of pharmaceuticals and medical devices.

The medac group is strengthening its international brand identity. As of 1 April 2026, the company’s production sites in Brno and Dessau operate under the shared name medac pharma production.

Today medac, a globally active pharmaceutical company specialising in therapeutic solutions for oncology, rheumatology, urology and hematology, announced the acquisition of Biotech Pharma, based in Dubai.